Jerliu Aulon, Taritsa Iulianna C, Foppiani Jose, Lee Daniela, Hersh David, Lin Samuel J, Hughes Christopher D
From the Department of Surgery, University of Connecticut School of Medicine, Farmington, CT.
Division of Plastic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Plast Reconstr Surg Glob Open. 2025 Mar 3;13(3):e6588. doi: 10.1097/GOX.0000000000006588. eCollection 2025 Mar.
Bioresorbable plating systems have been more recently developed as an alternative to metal osteofixation systems and can be used for craniosynostosis operations. To date, the bioresorbable materials used for osteofixation have been used clinically with excellent safety outcomes and good patient outcomes without major plate-induced complications. In this report, we present 2 cases in which bioresorbable materials failed to degrade following operations for craniosynostosis in a chronic manner mandating removal and revision. We also provide a review of the existing literature regarding bioresorbable fixation and evidence of failure to degrade. Based on the clinical courses and pathological findings, it is likely that material factors, combined with the metabolic resorptive capacity and the patient host immune system, contributed to the failure of resorption. Treatment with the removal of implant debris has proven to be effective in other reports, and both patients ultimately progressed with acceptable clinical outcomes. Evaluating rare complications associated with these systems will help provide evidence to inform future product development and refinement. As the field of craniofacial surgery continues to evolve, the use of new materials and technologies promises to enhance patient outcomes, reduce complications, and expand the scope of surgical interventions.
生物可吸收接骨板系统是最近开发的一种替代金属骨固定系统的产品,可用于颅缝早闭手术。迄今为止,用于骨固定的生物可吸收材料已在临床上使用,具有出色的安全性和良好的患者预后,且未出现由接骨板引起的重大并发症。在本报告中,我们介绍了2例生物可吸收材料在颅缝早闭手术后未能以慢性方式降解,从而需要取出和翻修的病例。我们还对有关生物可吸收固定以及未能降解的证据的现有文献进行了综述。根据临床病程和病理结果,材料因素、代谢吸收能力和患者自身免疫系统可能共同导致了吸收失败。在其他报告中,去除植入物碎片的治疗已被证明是有效的,并且两名患者最终都取得了可接受的临床结果。评估与这些系统相关的罕见并发症将有助于为未来产品的开发和改进提供依据。随着颅面外科领域的不断发展,新材料和技术的使用有望改善患者预后、减少并发症并扩大手术干预的范围。